Four Months of Momentum: Adhera Health’s Breakthroughs in Empathic AI, Clinical Evidence, and Industry Recognition
From ENDO 2025 to DTM to AIMed25, Adhera Health has been on a remarkable trajectory. Our research was featured by the Endocrine Society, our AI Health Agentic Platform drew strong interest from diabetes innovators, and our empathic AI approach won First Place at AIMed25’s Shark Tank competition. This momentum signals a shift: family-centered, emotionally intelligent AI is emerging as the future of pediatric chronic care.
The past several months has been a remarkable period of growth, validation, and recognition for Adhera Health. From publishing three peer-reviewed studies to presenting at ENDO 2025, participating in the Diabetes Technology Meeting’s Startup Showcase, and winning the AIMed25 Shark Tank competition - one theme has been consistent: Empathic AI is resonating across the entire healthcare ecosystem.
This momentum represents years of work building emotionally intelligent, family-centered technologies that support families, clinicians, and care teams in pediatric chronic care.
Three New Peer-Reviewed Studies in JMIR Pediatrics & Parenting
This year, we published three studies in JMIR Pediatrics & Parenting validating the impact of our digital programs across pediatric chronic conditions.
1. Enhancing Adherence and Mental Well-being in Pediatric Growth Hormone Therapy
This study demonstrated improvements in adherence, emotional well-being, and confidence among families using a family-centered digital companion during pediatric GHD therapy.
JMIR Pediatrics & Parenting Published on 27.Oct.2025
This is a visual abstract summarizing the key findings of the research titled "Enhancing Adherence and Mental Well-Being in Pediatric Growth Hormone Therapy: Feasibility Prospective Observational Study of a Family-Centered Digital Companion," published in JMIR Pediatrics and Parenting in 2025. The study found that the Adhera Caring Digital Program significantly improves treatment adherence and enhances caregivers’ quality of life.
2. Empowering Caregiver Well-Being for Families Managing Type 1 Diabetes
This publication showed meaningful reductions in caregiver depression and anxiety, along with improved confidence and treatment adherence.
JMIR Pediatrics & Parenting Published on 05.Feb.2025
This is a visual abstract summarizing the key findings of the research titled "Empowering Caregiver Well-Being With the Adhera Caring Digital Program for Family Caregivers of Children Living With Type 1 Diabetes: Mixed Methods Feasibility Study," published in JMIR Pediatrics and Parenting in 2025. The study found that the Adhera Caring Digital Program improved caregivers’ psychological well-being and self-efficacy, suggesting that digital solutions can support caregiver mental health and enhance diabetes management.
3. Digital Health Support for Caregivers of Children Undergoing Growth Hormone Therapy
This qualitative analysis revealed emotional and behavioral benefits for caregivers supporting children through growth hormone therapy.
JMIR Pediatrics & Parenting Published on 05.Feb.2025
This is a visual Abstract of the paper titled: Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: a Qualitative Feasibility Study.
Scientific Leadership at ENDO 2025
Our Growth Hormone Disorder study, conducted with the Pediatric Endocrinology Department at Hospital Miguel Servet and supported by Merck, was selected both as a poster and for the highly competitive Rapid Fire format. Presented by Luis Fernández Luque, PhD, Adhera Health’s Chief Scientific Officer, the research was also chosen as one of just 24 abstracts (out of more than 2,700) featured in the Endocrine Society’s official press releases. The study emphasized the strong relationship between caregiver mental health and a child’s coping, adherence, and clinical trajectory - reinforcing the need for holistic, family-centered interventions that account for the shared emotional experience of GHD.
Our T1D presentation, supported by Novo Nordisk, explored how severe hypo- and hyperglycemic events - especially at night - impact not only children’s well-being but also caregiver stress and children’s academic performance.
And through our NIH-funded partnership with Children’s Hospital Los Angeles, we brought forward the lived experiences of Latino families managing childhood obesity, revealing cultural, emotional, and structural challenges that point to an urgent need for more culturally competent, emotionally supportive tools.
Together, these studies reflect Adhera Health’s growing scientific momentum and reinforce our commitment to advancing emotionally intelligent, family-centered digital support across pediatric chronic conditions.
Startup Showcase at the 2025 Diabetes Technology Meeting
On October 28, Adhera Health was featured in the Startup Showcase at the Diabetes Technology Meeting (DTM), hosted by the Diabetes Technology Society and co-sponsored by the American Diabetes Association. Being selected for this stage allowed us to share our growing body of scientific evidence and highlight the real-world needs of families managing complex pediatric chronic conditions.
At DTM, we presented our evolution from the Adhera Caring Digital Program (ACDP) to our AI Health Agentic Platform, illustrating how emotionally intelligent, family-centered AI can extend clinical care into the home. We demonstrated how our agents support families navigating Type 1 Diabetes and obesity/pre-diabetes, addressing not only treatment adherence but also the behavioral, emotional, and cultural factors that shape a child's health journey. This milestone further reinforced our momentum as we continue to advance next-generation digital tools that meet families where they are.
AIMed25 Shark Tank Winner
And just last week, Adhera Health achieved one of our most exciting milestones yet - winning First Place at the AIMed25 Shark Tank competition in San Diego, California. Competing among some of the most innovative AI-driven healthcare companies, our vision for family-centered pediatric chronic care stood out clearly to the judges.
They highlighted the strength of our approach, including:
Emotionally intelligent AI Health Agents that extend compassionate support into the home
Small Language Models (SLMs) trained on real whole-family data
Clinically validated impact, backed by peer-reviewed studies and real-world evidence
A family-centered design philosophy that supports children, caregivers, clinicians, and care teams
This recognition underscores what we believe deeply: Empathic AI isn’t just a technological advance - it’s the foundation of modern pediatric chronic care.
A Unified Digital Ecosystem
Adhera Health connects families, clinicians, care teams, payors, and employers in a unified digital ecosystem that bridges clinical care and real-world family life.
Our AI Health Agents enable:
Family-centered pediatric chronic care management
Emotionally intelligent support in the home
Improved adherence, engagement, and caregiver well-being
Actionable insights for health systems and employers
Better coordination across the care continuum
By linking clinical outcomes to the day-to-day lives of families, our platform reduces both the human and financial burden of pediatric chronic conditions.
Conclusion
This season of recognition - three JMIR studies, ENDO presentations, DTM Showcase participation, and the AIMed25 win - marks a defining moment for Adhera Health.
We set out to build technology rooted in empathy and science. Today, with growing validation across research, clinical communities, and innovation platforms, that vision is taking shape in powerful ways.
Empathic AI isn’t the future - it’s what families need right now.